Clinical Trials Logo

Filter by:
NCT ID: NCT06386055 Not yet recruiting - Physical Inactivity Clinical Trials

Air Pollution and Physical Activity: A Randomized Controlled Trial

PARC
Start date: June 15, 2024
Phase: N/A
Study type: Interventional

This is a small pilot intervention trial in which we will collect preliminary data to demonstrate the feasibility of an intervention study.

NCT ID: NCT06386029 Not yet recruiting - Autism Clinical Trials

The Power Down Pilot Study: A Novel Bedtime Manipulation Protocol

Start date: May 2024
Phase: N/A
Study type: Interventional

The goal of this pilot intervention study is to examine the feasibility and acceptability of a novel bedtime manipulation protocol called "The Power Down" for autistic youth, ages 6-10. The main questions it aims to answer are: 1. Is the Power Down feasible for caregivers to do each night? 2. Do the families find the Power Down an acceptable intervention to address their child's difficulties settling down to fall asleep?

NCT ID: NCT06385392 Not yet recruiting - Parkinson Disease Clinical Trials

Continuous Wearable Monitor for the Detection and Release of Freezing of Gait.

Start date: May 2024
Phase:
Study type: Observational

The proposed system (haptic module and insole device) for daily in-community use that detects the occurrence of freezing of gait (FOG) in people with Parkinson's disease (PD). and triggers external cueing stimuli to unfreeze the individual. The purpose of the overall Phase II study is to: (1) Develop a production ready system, (2) Develop a companion mobile app for the proposed system and refine previously developed FOG detection algorithms, and (3) Validate the proper operation of the system and demonstrate its efficacy through lab and in-community testing. This study will focus on validating the system and demonstrating efficacy through in-community testing.

NCT ID: NCT06385275 Not yet recruiting - Clinical trials for Osteo Arthritis Knee

The Role of Vitamin K on Knee Osteoarthritis Outcomes

Start date: September 2024
Phase: Phase 1/Phase 2
Study type: Interventional

The appropriate form and dosing of vitamin K to benefit relevant outcomes in knee osteoarthritis (OA) are not known. In intervention studies for conditions other than knee OA (e.g., prevention of cardiovascular disease), the most commonly used forms and doses include phylloquinone (vitamin K1; 1000µg or 500µg daily) or menaquinone-7 (MK-7 or vitamin K2; 360µg daily). However, whether these doses are adequate to increase vitamin K to levels that ameliorate risk of adverse OA outcomes is not known. Furthermore, although some studies suggest enhanced bioavailability of MK-7 over vitamin K1, as well as extra-hepatic effects, whether this is relevant for an older population with knee OA is not known, The overall goal of this pilot randomized clinical trial (RCT) is to test different subtypes and doses of vitamin K supplementation in older adults with knee OA and to measure changes in relevant biochemical measures.

NCT ID: NCT06384989 Not yet recruiting - Safety Issues Clinical Trials

Safety-Enhancing Motor Vehicle Child Safety Seat

Start date: May 1, 2024
Phase:
Study type: Observational

This study aims to assess the usability of a load leg design for caregivers who must install the child safety seat into a vehicle. The specific aims are to quantify any errors committed by the participants while installing the car seat and to assess participants' opinions on the car seat's load leg design.

NCT ID: NCT06384924 Not yet recruiting - Clinical trials for Squamous Cell Carcinoma

Raman Spectroscopy and Skin Cancer

Start date: May 16, 2024
Phase:
Study type: Observational

The goal of this observational study is to find out if Raman Spectroscopy, a type of imaging, can be used to determine the size of skin cancer tumors. The main question it aims to answer is: -Can Raman Spectroscopy help figure out how far a tumor spreads? This study will take measurements using laser light from an experimental, handheld probe by lightly touching the skin.

NCT ID: NCT06384898 Not yet recruiting - Knee Osteoarthritis Clinical Trials

Remote Tai Chi for Knee Osteoarthritis

TAICHIKNEE
Start date: September 2024
Phase: N/A
Study type: Interventional

The goal of this pragmatic randomized trial is to evaluate the effectiveness of remote Tai Chi to treat knee pain in adults with knee osteoarthritis. The main questions the trial aims to answer are: - Does remote Tai Chi improve the extent to which pain interferes with physical, mental, and social activities (PROMIS-Pain Interference at 3 months, primary outcome), as well as knee pain and function (WOMAC subscales) and analgesic use (secondary outcomes) - Does remote tai chi decreases healthcare utilization? Researchers will compare remote Tai Chi added to routine care to routine care alone to see if remote tai chi works to treat knee osteoarthritis pain. Participants will participate in remotely delivered web-based tai chi sessions, twice a week for 12 weeks, or will continue to receive routine care. Participants will be followed for 12 months after randomization.

NCT ID: NCT06384742 Not yet recruiting - Clinical trials for Shift Work Type Circadian Rhythm Sleep Disorder

Shift Worker Intervention for Sleep Health

SWISH
Start date: September 2024
Phase: N/A
Study type: Interventional

The aim of this study is to pilot test a comprehensive, personalized, media-augmented telehealth intervention ("SWISH") designed to improve sleep health among shift workers.

NCT ID: NCT06384664 Not yet recruiting - Pain, Postoperative Clinical Trials

Cryoablation Effects on Acute and Chronic Pain After Thoracotomy and Thoracoscopy

Start date: May 20, 2024
Phase: N/A
Study type: Interventional

The researchers will compare the common methods of post-surgical pain control, such as epidural or intercostal nerve block with a newer method called cryoablation. The research team is conducting this study to determine if cryoablation provides more effective pain control when compared to an epidural or intercostal nerve block.

NCT ID: NCT06384573 Not yet recruiting - Dementia Clinical Trials

DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease

DIAN-TU
Start date: June 2024
Phase: Phase 3
Study type: Interventional

This is an open label study to treat dominantly inherited Alzheimer's disease (DIAD) mutation carrier participants from the DIAN-TU-001 gantenerumab Open Label Extension (OLE) period with lecanemab to determine the effects of amyloid removal on age of onset and clinical progression compared to external controls, if amyloid plaque as measured by amyloid PET can be fully removed in DIAD, and the effects of amyloid removal on biomarkers of disease progression.